zum Inhalt

Dr. Andreas WALLNÖFER Global Head of Development, pRED - Pharma Research & Exploratory Development, F. Hoffmann-La Roche AG, Basel

CV

 Ph.D. at the University of Basel, Post-doc fellowship in Clinical Pharmacology at the University Hospital Leiden, Netherlands; Business training at IMD Lausanne
1987 Basic Research, Cardiovascular Discovery Research, Sandoz
1991 Clinical Investigator, Centre for Human Drug Research, Leiden
1992 Clinical Pharmacologist, Roche
1996 Clinical Science and Clinical Team Leader, Cardiovascular Clinical Research, Roche
1999 Project Leader, R&D Project Management, Roche
2002 Global Head, Early Development Project Leaders and Project Management, Roche
2007 Global Head, Clinical Research & Exploratory Development, Roche
2010 Global Head of Development, Roche Pharma Research & Exploratory Development (pRED)

Mitgliedschaften

Roche Pharma R&D leadership team
Research & Exploratory as well as Late stage, Roche Genentech Strategic Portfolio Committees
Expert commission, Swiss Academy of Medical Sciences
Steering Committee of the Singapore Translational Medicine Hub
University of Basel Pharma Center Council